Filtered By:
Condition: Hypertension
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 587 results found since Jan 2013.
miR-145 Alleviates Smooth Muscle Cell Phenotype Transition via ADAM17-Mediated ACE2 Shedding
In conclusion, miR-145 alleviates phenotype transition from contractile to synthetic type via ADAM17-mediated ACE2 shedding in VSMCs and retains the activation of ACE2-Ang-(1-7)-Mas axis, which may benefit the vascular structural remodeling in the metabolic hypertension.PMID:37521117 | PMC:PMC10374374 | DOI:10.1155/2023/9497716
Source: International Journal of Hypertension - July 31, 2023 Category: Cardiology Authors: Juan Wen Baiyi Tang Lan Guo Wei Chen Xiaohong Tang Source Type: research
Promising novel siRNA for the treatment of hypertension
Nature Reviews Cardiology, Published online: 31 July 2023; doi:10.1038/s41569-023-00916-9Patients with hypertension who receive a single subcutaneous dose of zilebesiran, a novel small-interfering RNA that inhibits hepatic angiotensinogen synthesis, have reductions in serum angiotensinogen levels and 24-h ambulatory blood pressure that last for up to 24 weeks, according to a phase I study.
Source: Nature Reviews Cardiology - July 31, 2023 Category: Cardiology Authors: Irene Fern ández-Ruiz Source Type: research
